Matches in SemOpenAlex for { <https://semopenalex.org/work/W2336287130> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2336287130 endingPage "81" @default.
- W2336287130 startingPage "72" @default.
- W2336287130 abstract "Objective. To study the immunotherapy role in preventing edematous exophthalmos (EE). Matherials and methods. 19 patients with EE were examined: 8 people (16 eyes) with diffuse toxic goiter (DTG) on the stage of preparation for surgery or for radioactive iodine therapy, 4 people (8 eyes) with autoimmune thyroiditis (AIT), and 7 people (14 eyes) with both AIT and DTG. In all patients, a dry eye syndrome and highly active form of systemic disease were found. In the first group, to prevent edematous exophthalmos decompensation, a standard glucocorticosteroid (GC) pulse therapy during 3 days was performed; in the second group, intravenous (i/v) GC therapy during 2 days and i/v pentoxyfilline therapy; and in the third group, intravenous (i/v) GC therapy during 2 days, i/v pentoxyfilline therapy, and Restasis instillations. In all groups, a background treatment of thyroid disease was carried out. Results. Restasis therapy in edematous exophthalmos (EE) promoted not only dry eye signs leveling, but, in combination with cytokine blocker pentoxyfilline, lead to IOP and exophthalmos decrease, thus contributing to an amelioration of the optic nerve condition. Individualized approach to EE treatment consists in prevention of keratoconjunctivitis sicca and of other complications by 6 months Restasis therapy. Dry eye in endocrine ophthalmopathy (EO) will probably attract attention of endocrinologists and ophthalmologists as an early syndrome of individual predisposition to the development of complication cascade related to endocrine ophthalmopathy (EO)/ Conclusion. The proposed combined treatment appeared to be effective in influencing IOP decrease, dry eye syndrome signs and exophthalmos leveling, and acting on the optic neuropathy course." @default.
- W2336287130 created "2016-06-24" @default.
- W2336287130 creator A5059620611 @default.
- W2336287130 creator A5076282365 @default.
- W2336287130 date "2015-12-15" @default.
- W2336287130 modified "2023-09-23" @default.
- W2336287130 title "The immunotherapy role in ocular hypertension management" @default.
- W2336287130 cites W1975366623 @default.
- W2336287130 cites W1981862080 @default.
- W2336287130 cites W1984758930 @default.
- W2336287130 cites W1993174539 @default.
- W2336287130 cites W2002978736 @default.
- W2336287130 cites W2003447435 @default.
- W2336287130 cites W2014543513 @default.
- W2336287130 cites W2023660047 @default.
- W2336287130 cites W2032054048 @default.
- W2336287130 cites W2063793734 @default.
- W2336287130 cites W2073984265 @default.
- W2336287130 cites W2076339827 @default.
- W2336287130 cites W2080556279 @default.
- W2336287130 cites W2082804153 @default.
- W2336287130 cites W2089992103 @default.
- W2336287130 cites W2098140756 @default.
- W2336287130 cites W2120711134 @default.
- W2336287130 cites W2138168308 @default.
- W2336287130 cites W2334870842 @default.
- W2336287130 cites W4245219432 @default.
- W2336287130 cites W4249795250 @default.
- W2336287130 cites W65627649 @default.
- W2336287130 doi "https://doi.org/10.17816/ov2015372-81" @default.
- W2336287130 hasPublicationYear "2015" @default.
- W2336287130 type Work @default.
- W2336287130 sameAs 2336287130 @default.
- W2336287130 citedByCount "0" @default.
- W2336287130 crossrefType "journal-article" @default.
- W2336287130 hasAuthorship W2336287130A5059620611 @default.
- W2336287130 hasAuthorship W2336287130A5076282365 @default.
- W2336287130 hasConcept C118487528 @default.
- W2336287130 hasConcept C126322002 @default.
- W2336287130 hasConcept C141071460 @default.
- W2336287130 hasConcept C16005928 @default.
- W2336287130 hasConcept C2775847430 @default.
- W2336287130 hasConcept C2776521421 @default.
- W2336287130 hasConcept C2776652619 @default.
- W2336287130 hasConcept C2776685619 @default.
- W2336287130 hasConcept C2778696486 @default.
- W2336287130 hasConcept C2778837293 @default.
- W2336287130 hasConcept C2781092963 @default.
- W2336287130 hasConcept C526584372 @default.
- W2336287130 hasConcept C71924100 @default.
- W2336287130 hasConceptScore W2336287130C118487528 @default.
- W2336287130 hasConceptScore W2336287130C126322002 @default.
- W2336287130 hasConceptScore W2336287130C141071460 @default.
- W2336287130 hasConceptScore W2336287130C16005928 @default.
- W2336287130 hasConceptScore W2336287130C2775847430 @default.
- W2336287130 hasConceptScore W2336287130C2776521421 @default.
- W2336287130 hasConceptScore W2336287130C2776652619 @default.
- W2336287130 hasConceptScore W2336287130C2776685619 @default.
- W2336287130 hasConceptScore W2336287130C2778696486 @default.
- W2336287130 hasConceptScore W2336287130C2778837293 @default.
- W2336287130 hasConceptScore W2336287130C2781092963 @default.
- W2336287130 hasConceptScore W2336287130C526584372 @default.
- W2336287130 hasConceptScore W2336287130C71924100 @default.
- W2336287130 hasIssue "3" @default.
- W2336287130 hasLocation W23362871301 @default.
- W2336287130 hasOpenAccess W2336287130 @default.
- W2336287130 hasPrimaryLocation W23362871301 @default.
- W2336287130 hasRelatedWork W1971364190 @default.
- W2336287130 hasRelatedWork W2040610018 @default.
- W2336287130 hasRelatedWork W2066389599 @default.
- W2336287130 hasRelatedWork W2336287130 @default.
- W2336287130 hasRelatedWork W2397512683 @default.
- W2336287130 hasRelatedWork W2741680205 @default.
- W2336287130 hasRelatedWork W2921058445 @default.
- W2336287130 hasRelatedWork W3032717496 @default.
- W2336287130 hasRelatedWork W4317639471 @default.
- W2336287130 hasRelatedWork W2337247042 @default.
- W2336287130 hasVolume "8" @default.
- W2336287130 isParatext "false" @default.
- W2336287130 isRetracted "false" @default.
- W2336287130 magId "2336287130" @default.
- W2336287130 workType "article" @default.